Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-26

Clinical Trial Update: A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001 [Phase 2]

View source ↗

Summary

This Phase 2 pharmacokinetic study comparing absorption, metabolism, and elimination of CHF 6001 in adolescents and adults with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHF 6001

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED